Home › Compare › NETDW vs MRK

NETDW vs MRK: Dividend Comparison 2026

NETDW yields 153846.15% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NETDW wins by $3.570817397657267e+28M in total portfolio value
10 years
NETDW
NETDW
● Live price
153846.15%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.570817397657267e+28M
Annual income
$35,662,574,083,913,823,000,000,000,000,000,000.00
Full NETDW calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — NETDW vs MRK

📍 NETDW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNETDWMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NETDW + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NETDW pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NETDW
Annual income on $10K today (after 15% tax)
$13,076,923.08/yr
After 10yr DRIP, annual income (after tax)
$30,313,187,971,326,747,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, NETDW beats the other by $30,313,187,971,326,747,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NETDW + MRK for your $10,000?

NETDW: 50%MRK: 50%
100% MRK50/50100% NETDW
Portfolio after 10yr
$1.7854086988286334e+28M
Annual income
$17,831,287,041,956,911,000,000,000,000,000,000.00/yr
Blended yield
99.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NETDW
No analyst data
Altman Z
-0.3
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NETDW buys
0
MRK buys
0
No recent congressional trades found for NETDW or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNETDWMRK
Forward yield153846.15% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$3.570817397657267e+28M$30.7K ✓
Annual income after 10y$35,662,574,083,913,823,000,000,000,000,000,000.00 ✓$950.29
Total dividends collected$3.5705187474861104e+28M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NETDW vs MRK ($10,000, DRIP)

YearNETDW PortfolioNETDW Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$15,395,315$15,384,615.38$11,192$351.54+$15.38M → NETDW
2$22,152,081,017$22,135,608,029.64$12,524$392.70+$22152.07M → NETDW
3$29,790,603,453,124$29,766,900,726,435.82$14,015$438.65+$29790603.44M → NETDW
4$37,444,193,407,360,220$37,412,317,461,665,380.00$15,682$489.96+$37444193407.34M → NETDW
5$43,987,751,239,956,050,000$43,947,685,953,010,180,000.00$17,547$547.23+$43987751239956.04M → NETDW
6$48,297,311,048,679,450,000,000$48,250,244,154,852,700,000,000.00$19,632$611.16+$48297311048679448.00M → NETDW
7$49,563,274,505,183,440,000,000,000$49,511,596,382,361,350,000,000,000.00$21,963$682.53+$49563274505183444992.00M → NETDW
8$47,538,442,557,656,110,000,000,000,000$47,485,409,853,935,560,000,000,000,000.00$24,571$762.18+$4.753844255765611e+22M → NETDW
9$42,616,722,111,071,980,000,000,000,000,000$42,565,855,977,535,280,000,000,000,000,000.00$27,486$851.08+$4.261672211107198e+25M → NETDW
10$35,708,173,976,572,667,000,000,000,000,000,000$35,662,574,083,913,823,000,000,000,000,000,000.00$30,745$950.29+$3.570817397657267e+28M → NETDW

NETDW vs MRK: Complete Analysis 2026

NETDW — Stock

Nabors Energy Transition Corp. II focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify solutions, opportunities, companies, or technologies that focus on advancing the energy transition that facilitate, improve, or complement the reduction of carbon or greenhouse gas emissions. The company was incorporated in 2023 and is based in Houston, Texas. Nabors Energy Transition Corp. II is a subsidiary of Nabors Energy Transition Sponsor II LLC.

Full NETDW Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this NETDW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NETDW vs SCHDNETDW vs JEPINETDW vs ONETDW vs KONETDW vs MAINNETDW vs JNJNETDW vs ABBVNETDW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.